Skip to main navigation
Skip to main content
Skip to Footer
Blog
Clinical Trials
Contact Us
Careers
Home
Our Motivation
Patient Stories
Annabelle
Isabel
Matty
Miller
Sarah
Diseases & Conditions
Achondroplasia
PKU
CLN2 Disease
MPS VI
MPS IVA
MPS I
Patient & Community Support
Trees of Life
RARE Scholars
In the Hemophilia Community
Patient Advocacy
BioMarin RareConnections™
Grants & Donations
Resource Library
Professional Organizations
Our Science
Our Approach
Technical Expertise
Indication Expansion
Franchise Building
Our Scientists
Our Publications
Science Spotlight
Advancing our understanding of gene therapy research, one publication at a time
Zeroing in on Therapeutic Drug Targets
Meet Christian Vettermann, Ph.D.
Center of Technology (CoTe)
Funding & Support
Independent Medical Education
Independent and Collaborative Research
Grants & Donations
Publication Data Request
Our Treatments
Our Products
VOXZOGO™ (vosoritide) Injection for Achondroplasia
PALYNZIQ
®
(pegvaliase-pqpz) Injection for PKU
Brineura
®
(cerliponase alfa) for CLN2 Disease
Vimizim
®
(elosulfase alfa) for Morquio A Syndrome (MPS IVA)
Kuvan
®
(sapropterin dihydrochloride) for PKU
Aldurazyme
®
(laronidase) for MPS I
Naglazyme
®
(galsulfase) for MPS VI
Our Pipeline
Valoctocogene Roxaparvovec for Severe Hemophilia A
BMN 307 for Phenylketonuria (PKU)
BMN 331 for Hereditary Angioedema (HAE)
Compassionate Use Policy
Our Company
About Us
Our History
Manufacturing Excellence
Message from Chairman and CEO
Global Compliance & Ethics
Corporate Social Responsibility
Diversity, Equity & Inclusion
Environmental Health, Safety & Sustainability (EHS&S)
Leadership Team
Jean-Jacques Bienaimé
Henry J. Fuchs, M.D.
Jeff Ajer
G. Eric Davis
C. Greg Guyer, Ph.D.
Brian R. Mueller
Philip Lo Scalzo
Amy Wireman
Brinda Balakrishnan, M.D., Ph.D.
Board of Directors
Funding & Support
Independent Medical Education
Independent and Collaborative Research
Grants & Donations
Investors & Media
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Analyst Coverage
Stock Information
Investor FAQs
Contact Us
Email Alerts
Search
our website
Close
Our Motivation
Patient Stories
Diseases & Conditions
Patient & Community Support
Resource Library
Our Science
Our Approach
Our Scientists
Our Publications
Science Spotlight
Funding & Support
Our Treatments
Our Products
Our Pipeline
Compassionate Use Policy
Our Company
About Us
Corporate Social Responsibility
Leadership Team
Board of Directors
Funding & Support
Investors & Media
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Analyst Coverage
Stock Information
Investor FAQs
Contact Us
Email Alerts
Privacy Policy
Terms of Use
LinkedIn
Facebook
Site Map
Instagram
Supplier Information
YouTube
Glossary
© 2022 BioMarin. All rights reserved.
Report a Product Complaint
Contact Us
Locations
Global Medical Information
Report Adverse Event
Report a Product Complaint
Search
Get in touch with us.
*required fields
First Name
*
Last Name
*
Email Address
*
Profession
*
Please make a selection
Patient/Caregiver
Patient Advocacy Org
Healthcare Professional (HCP)
Student HCP
Health Agency
Insurer
Investor
Legal
Media
Publisher
Regulatory
Student
Wholesaler
Other
Please select a product
*
Please make a selection
PALYNZIQ
Brineura
Vimizim
Kuvan
Naglazyme
Aldurazyme
No Product Specified
Other
Other Product
*
Description/Complaint
*
Please enter the captcha below
Comments
This field is for validation purposes and should be left unchanged.
Home
›
Contact Us
›
Report a Product Complaint
